Promethazine/hydrocodone/paracetamol - Charleston Laboratories

Drug Profile

Promethazine/hydrocodone/paracetamol - Charleston Laboratories

Alternative Names: CL-108; HYDEXOR; Hydrocodone/paracetamol/promethazine; Paracetamol/promethazine/hydrocodone

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Charleston Laboratories
  • Class Acetanilides; Antiemetics; Antipyretics; Morphinans; Non-opioid analgesics; Opioid analgesics; Propylamines
  • Mechanism of Action Histamine H1 receptor antagonists; Muscarinic receptor antagonists; Opioid receptor agonists; Prostaglandin receptor antagonists; Serotonin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Acute pain; Nausea and vomiting

Most Recent Events

  • 12 Sep 2018 Efficacy data from a phase II trial in Acute pain and Nausea and vomiting presented at the World Congress on Pain (WCP-2018)
  • 01 Aug 2018 Chemical structure information added
  • 01 Aug 2018 Phase-III clinical trials in Acute pain in USA (PO, Tablet, 12.5mg/10mg/325mg) (Charleston Laboratories pipeline, August 2018)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top